ATE483984T1 - Messung der thrombinaktivität in vollblut - Google Patents

Messung der thrombinaktivität in vollblut

Info

Publication number
ATE483984T1
ATE483984T1 AT06753838T AT06753838T ATE483984T1 AT E483984 T1 ATE483984 T1 AT E483984T1 AT 06753838 T AT06753838 T AT 06753838T AT 06753838 T AT06753838 T AT 06753838T AT E483984 T1 ATE483984 T1 AT E483984T1
Authority
AT
Austria
Prior art keywords
thrombinactivity
measurement
whole blood
blood
whole
Prior art date
Application number
AT06753838T
Other languages
English (en)
Inventor
Hendrik Hemker
Suzette Beguin
Raed Al-Dieri
Robert Wagenvoord
Sabastiaan Nijhuis
Peter Giesen
Original Assignee
Synapse Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synapse Bv filed Critical Synapse Bv
Application granted granted Critical
Publication of ATE483984T1 publication Critical patent/ATE483984T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT06753838T 2005-04-29 2006-04-26 Messung der thrombinaktivität in vollblut ATE483984T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05290952A EP1717588A1 (de) 2005-04-29 2005-04-29 Bestimmung der Thrombinaktivität in Vollblut
PCT/EP2006/004945 WO2006117246A1 (en) 2005-04-29 2006-04-26 Measuring thrombin activity in whole blood

Publications (1)

Publication Number Publication Date
ATE483984T1 true ATE483984T1 (de) 2010-10-15

Family

ID=34978991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06753838T ATE483984T1 (de) 2005-04-29 2006-04-26 Messung der thrombinaktivität in vollblut

Country Status (16)

Country Link
US (1) US8916356B2 (de)
EP (2) EP1717588A1 (de)
JP (1) JP4897794B2 (de)
KR (1) KR20080025043A (de)
CN (1) CN101171519A (de)
AR (1) AR053371A1 (de)
AT (1) ATE483984T1 (de)
AU (1) AU2006243283B2 (de)
BR (1) BRPI0612967B8 (de)
CA (1) CA2606906C (de)
DE (1) DE602006017350D1 (de)
ES (1) ES2354086T3 (de)
MX (1) MX2007013497A (de)
RU (1) RU2422835C2 (de)
TW (1) TW200716982A (de)
WO (1) WO2006117246A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029768B1 (de) * 2006-06-06 2013-02-13 Thrombinoscope B.V. Verfahren zur bestimmung der thrombinaktivität in plasma
CA2668356A1 (en) * 2006-11-02 2008-05-08 Thrombinoscope B.V. Method for measuring the concentration of transient proteolytic activity in composite biological media containing cells
EP2088435B1 (de) 2008-02-07 2011-07-13 Synapse B.V. Um den Einfluss von Störfaktoren korrigierte Messung des zeitlichen Verlaufs einer enzymatischen Aktivität bei der Reaktion eines Enzyms mit einem Substrat
FR2933496B1 (fr) * 2008-07-02 2012-10-05 Lfb Biotechnologies Procede de mesure du taux de facteur vii active dans un echantillon
EP2316035A2 (de) * 2008-07-16 2011-05-04 Radiometer Medical ApS Thrombinsubstrat und testverfahren zur bestimmung des spiegels von biologisch aktivem thrombin in einer probe
EP2313785B1 (de) 2008-08-05 2016-02-17 Synapse B.V. Verfahren und Vorrichtung zur Messung der Erzeugung von Thrombin in Plasma
JP5582745B2 (ja) * 2009-09-09 2014-09-03 メタウォーター株式会社 化学発光反応の時間計測による被検出物質の濃度を測定する方法およびそれに使用するキット
US8293493B2 (en) * 2010-01-27 2012-10-23 Adventist Health System/Sunbelt, Inc. Thrombin generation determination method
CN102798598A (zh) * 2011-05-25 2012-11-28 兆科药业（合肥）有限公司 一种检测磷脂依赖性凝血因子x激活物酶活性的方法
RU2518247C2 (ru) * 2011-07-26 2014-06-10 Общество с ограниченной ответственностью "ГемаКор Лабс" (ООО "ГемаКор Лабс") Способ определения пространственно-временного распределения активности протеолитического фермента в гетерогенной системе, устройство для реализации указанного способа и способ диагностики нарушений системы гемостаза по изменению пространственно-временного распределения активности протеолитического фермента в гетерогенной системе
BR112014003787A2 (pt) 2011-08-23 2020-10-27 Synapse B.V. inibidores termoestáveis de ativação do sistema de coagulação sanguínea por contato com superfícies estranhas
WO2013101836A1 (en) * 2011-12-31 2013-07-04 The University Of Vermont And State Agriculture College Methods for dynamic visualization of clinical parameters over time
KR101383333B1 (ko) * 2012-01-13 2014-04-10 연세대학교 산학협력단 트롬빈 생성 측정 방법
EP2677037B1 (de) * 2012-06-21 2016-04-13 Synapse B.V. Gleichzeitige Messung der Thrombinerzeugung und Gerinnselfestigkeit in Plasma und im gesamten Blut
EP2937695B1 (de) * 2012-12-18 2018-10-24 Daiichi Sankyo Company, Limited Verfahren zur messung der thrombinerzeugung
CN103185710B (zh) * 2013-02-04 2015-01-07 中国医学科学院输血研究所 人静脉注射免疫球蛋白中活化凝血因子ⅺ检测方法
CN104977259A (zh) * 2014-04-04 2015-10-14 天津药物研究院 一种基于高通量检测的血小板聚集测定方法及在药物筛选中的应用
US9986941B2 (en) 2014-06-26 2018-06-05 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for rapid monitoring of hemostatic state
CN104459165B (zh) * 2014-12-10 2016-07-06 中国医学科学院输血研究所 一种检测人凝血酶原复合物抗凝能力的方法
US10633645B2 (en) * 2015-12-30 2020-04-28 General Electric Company Calcium controlled activation of platelets via electrical stimulation
JP7009998B2 (ja) 2016-01-29 2022-01-26 ソニーグループ株式会社 血液凝固系解析装置、血液凝固系解析システム、血液凝固系解析方法及び血液凝固系解析装置用パラメーターの決定方法
EP3363912B1 (de) 2017-02-17 2020-10-28 Synapse B.V. Selbstkalibrierter assay zur bestimmung der erzeugung von proteolytischem enzym, dedizierte mittel und verwendungen davon
CN107102125B (zh) * 2017-04-17 2019-07-09 中国科学院苏州生物医学工程技术研究所 血栓弹力图仪的校准方法
RU2709341C1 (ru) * 2019-04-19 2019-12-17 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) Определение циркулирующего тромбина в тесте активации системы комплемента
WO2021019529A1 (en) 2019-07-31 2021-02-04 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for identifying thrombus origin and optimizing post-ischemic event treatment
CN110412001B (zh) * 2019-08-01 2022-02-11 武汉塞力斯生物技术有限公司 一种动态监测凝血酶生成能力的试剂盒
JP7218878B2 (ja) * 2019-08-07 2023-02-07 学校法人東京歯科大学 判別方法、蛍光測定装置および検査薬
CN110568117B (zh) * 2019-09-19 2022-03-22 青岛海洋生物医药研究院股份有限公司 一种多靶点抗血栓活性物质的液相色谱-质谱筛选方法
CN116635532A (zh) 2020-12-21 2023-08-22 爱惜康股份有限公司 出血检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55164356A (en) * 1979-06-08 1980-12-22 Fuji Photo Film Co Ltd Multi-layer analysis sheet for liquid sample analysis
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
ES2151509T3 (es) * 1992-04-27 2001-01-01 Avocet Medical Inc Articulo de prueba y metodo para llevar a cabo ensayos de coagulacion de la sangre.
CA2484554C (en) * 2002-05-01 2012-12-04 Synapse B.V. Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media

Also Published As

Publication number Publication date
JP4897794B2 (ja) 2012-03-14
EP1875249B1 (de) 2010-10-06
AU2006243283A1 (en) 2006-11-09
AR053371A1 (es) 2007-05-02
JP2008539400A (ja) 2008-11-13
US20090311730A1 (en) 2009-12-17
CA2606906C (en) 2013-03-19
BRPI0612967B8 (pt) 2021-07-27
CN101171519A (zh) 2008-04-30
DE602006017350D1 (de) 2010-11-18
EP1875249A1 (de) 2008-01-09
BRPI0612967A2 (pt) 2010-12-14
MX2007013497A (es) 2008-04-04
EP1717588A1 (de) 2006-11-02
TW200716982A (en) 2007-05-01
WO2006117246A1 (en) 2006-11-09
RU2422835C2 (ru) 2011-06-27
RU2007137972A (ru) 2009-06-10
CA2606906A1 (en) 2006-11-09
ES2354086T3 (es) 2011-03-09
US8916356B2 (en) 2014-12-23
KR20080025043A (ko) 2008-03-19
AU2006243283B2 (en) 2011-06-30
BRPI0612967B1 (pt) 2021-02-02

Similar Documents

Publication Publication Date Title
ATE483984T1 (de) Messung der thrombinaktivität in vollblut
DE602005001730D1 (de) Gerät zur Messung der Körperzusammensetzung
DK2162879T3 (da) Lydstyrkemåling med spektrale ændringer
DE602005003147D1 (de) Messsystem
DE602005027638D1 (de) System zur Messung der Körperaktivität
DE602006009202D1 (de) Formmessgerät
DE602005010517D1 (de) Kindergeeignetes Körperzusammensetzungsmessgerät
DE602004025215D1 (de) Tastsonde
DE602006004641D1 (de) Interferometer und Formmessverfahren
DE602005002326D1 (de) Biomagnetisches Messgerät
ATE526881T1 (de) Nicht-invasive strömungsmessung
DE602006000455D1 (de) Sensormessfehler
NO20064995L (no) Elektronisk termometer med målested
DE602006002289D1 (de) Vorrichtung zur Messung der Körperzusammensetzung
EP1866619A4 (de) Konsistenzänderung und -messung
DE602005027188D1 (de) Dreidimensionales Messsystem
DE602005007495D1 (de) Gerät zur Messung der Stoffwechselaktivität
DE112004002995A5 (de) Differenzdruckmessumformereinheit
DE502005010530D1 (de) Sensor mit kapazitivem messprinzip
DE502005000300D1 (de) Tastkopf
FI20041589L (fi) Mittausanturi
ATE479905T1 (de) Einrichtung zur messung des verlustfaktors
DE602005016843D1 (de) Interferometrisches messsystem
DE112007000980A5 (de) Messinstrument in Zweileitertechnik
FI20045330L (fi) Mittaväline

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties